Company: AEMD
Filing Date: 2025-07-25
Form Type: DRS
Source: 0001683168-25-005397
Chunk: 40

Company: AETHLON MEDICAL INC
Filing Date: 2025-07-25
Form: DRS
Chunk 40
---
 to operate as a going concern could have a material adverse effect on our ability to effectively
conduct our business and could impair our ability to execute our strategy and implement our business objectives, thereby having a material
adverse effect on our business, financial condition and results of operations.

Risks Related to Our Securities and the Inducement Offering and Company Offering

The Inducement Warrants being registered are currently worth less than the exercise price, the Selling Securityholders are unlikely to exercise their Inducement Warrants and cash proceeds from an exercise are dependent upon the Company’s stock price.

The
Inducement Warrants being registered in the registration statement of which this prospectus forms a part of, have an exercise price of
$2.99 per share, while the closing price of the common stock was $1.35 per share on July 24, 2025. Since both the Inducement Warrants
are currently worth less than what an investor would pay per share, the Selling Securityholders are unlikely to exercise. Cash proceeds
associated with the exercise(s) of the Inducement Warrants, if any, are dependent on the Company’s stock price at the time of exercise.

The Company Offering is a best-efforts offering, no minimum amount of securities is required to be sold, and we may not raise the amount of capital we believe is required for our business plans, including our near-term business plans.

The placement agent has agreed
to use its reasonable best efforts to solicit offers to purchase the securities in the Company Offering. The placement agent has no obligation
to buy any of the securities from us or to arrange for the purchase or sale of any specific number or dollar amount of the securities.
There is no required minimum number of securities that must be sold as a condition to completion of this offering. Because there is no
minimum offering amount required as a condition to the closing of the Company Offering, the actual offering amount, placement agent fees
and proceeds to us are not presently determinable and may be substantially less than the maximum amounts set forth herein. We may sell
fewer than all of the securities offered hereby, which may significantly reduce the amount of proceeds received by us, and investors in
this offering will not receive a refund in the event that we do not sell an amount of securities sufficient to support our continued operations,
including our near-term continued operations. Thus, we may not raise the amount of capital we believe is required for our operations in
the short-term and may need to raise additional funds to complete